Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDA Orange Book
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 6'-n-methylgentamicin C
2. De 020
3. De-020
4. Gentamicin C2b
5. Kw 1062
6. Kw-1062
7. Sagamicin
8. Xk-62-2
1. Gentamicin C2b
2. 52093-21-7
3. Sagamicin
4. Santemycin
5. Micronomicin [inn]
6. Xk-62-2
7. 6'-n-methylgentamicin C1a
8. S9az0r40qv
9. Chebi:81283
10. Kw-1062
11. (2r,3r,4r,5r)-2-[(1s,2s,3r,4s,6r)-4,6-diamino-3-[(2r,3r,6s)-3-amino-6-(methylaminomethyl)oxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-5-methyl-4-(methylamino)oxane-3,5-diol
12. D-streptamine, O-2-amino-2,3,4,6-tetradeoxy-6-(methylamino)-alpha-d-erythro-hexopyranosyl-(1-4)-o-(3-deoxy-4-c-methyl-3-(methylamino)-beta-l-arabinopyranosyl-(1-6))-2-deoxy
13. Micromicin
14. Micromycin
15. Micronomicina
16. Micronomicine
17. Micronomicinum
18. Sagamicin (obs.)
19. Gentamicin C(sub 2b)
20. Antibiotic Kw 1062
21. Antibiotic Xk 62-2
22. Ncgc00183277-01
23. Unii-s9az0r40qv
24. Micronomicine [inn-french]
25. Micronomicinum [inn-latin]
26. Micronomicina [inn-spanish]
27. 6'-n-methylgentamicin C(sub 1a)
28. De 020
29. Micronomicin (dcf)
30. Kw 1062
31. Xk 62-2
32. Micronomicin [mi]
33. Micronomicin [who-dd]
34. Schembl147893
35. Chembl373081
36. Gtpl12162
37. Dtxsid401023736
38. Hy-b1915
39. Zinc8214612
40. Akos016010141
41. Db13274
42. Cs-0013973
43. C17706
44. D08219
45. Q6839784
46. D-streptamine, O-2-amino-6-(methylamino)-2,3,4,6-tetradeoxy-alpha-d-erythro-hexopyranosyl-(1-4)-o-(3-deoxy-4-c-methyl-3-(methylamino)-beta-l-arabinopyranosyl-(1-6))-2-deoxy-
47. O-2-amino-2,3,4,6-tetradeoxy-6-(methylamino)-.alpha.-d-erythro-hexopyranosyl-(1->4)-o-(3-deoxy-4-c-methyl-3-(methylamino)-.beta.-l-arabinopyranosyl-(1->6)-2-deoxy-d-streptamine
48. O-2-amino-2,3,4,6-tetradeoxy-6-(methylamino)-a-d-erythro-hexopyranosyl-(1->4)-o-(3-deoxy-4-c-methyl-3-(methylamino)-.beta.-l-arabinopyranosyl-(1->6))-2-deoxy-d-streptamine
49. O-2-amino-2,3,4,6-tetradeoxy-6-(methylamino)-a-d-erythro-hexopyranosyl-(1-4)-o-(3-deoxy-4-c-methyl-3-(methylamino)-beta-l-arabinopyranosyl-(1-6))-2-deoxy-d-streptamine
| Molecular Weight | 463.6 g/mol |
|---|---|
| Molecular Formula | C20H41N5O7 |
| XLogP3 | -4.5 |
| Hydrogen Bond Donor Count | 8 |
| Hydrogen Bond Acceptor Count | 12 |
| Rotatable Bond Count | 7 |
| Exact Mass | 463.30059866 g/mol |
| Monoisotopic Mass | 463.30059866 g/mol |
| Topological Polar Surface Area | 200 Ų |
| Heavy Atom Count | 32 |
| Formal Charge | 0 |
| Complexity | 607 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 12 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Anti-Bacterial Agents
Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)
S - Sensory organs
S01 - Ophthalmologicals
S01A - Antiinfectives
S01AA - Antibiotics
S01AA22 - Micronomicin
FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Global Sales Information
ABOUT THIS PAGE
A Micronomicin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Micronomicin, including repackagers and relabelers. The FDA regulates Micronomicin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Micronomicin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Micronomicin supplier is an individual or a company that provides Micronomicin active pharmaceutical ingredient (API) or Micronomicin finished formulations upon request. The Micronomicin suppliers may include Micronomicin API manufacturers, exporters, distributors and traders.
Micronomicin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Micronomicin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Micronomicin GMP manufacturer or Micronomicin GMP API supplier for your needs.
A Micronomicin CoA (Certificate of Analysis) is a formal document that attests to Micronomicin's compliance with Micronomicin specifications and serves as a tool for batch-level quality control.
Micronomicin CoA mostly includes findings from lab analyses of a specific batch. For each Micronomicin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Micronomicin may be tested according to a variety of international standards, such as European Pharmacopoeia (Micronomicin EP), Micronomicin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Micronomicin USP).
LOOKING FOR A SUPPLIER?
